Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis

Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis

Abstract Aims Wildtype transthyretin amyloid cardiomyopathy is an under‐recognized cause of heart failure in elderly patients. Transcatheter tricuspid valve repair is a newly emerging therapeutic option for severe tricuspid regurgitation (TR). We present first insights into safety and possible benef...

Full description

Bibliographic Details
Main Authors: Isabel A. Hoerbrand, Martin J. Volz, Fabian Aus dem Siepen, Matthias Aurich, Philipp Schlegel, Nicolas A. Geis, Ute Hegenbart, Mathias H. Konstandin, Norbert Frey, Philip W. Raake
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Transcatheter tricuspid valve repair
Tricuspid regurgitation
Cardiac amyloidosis
Amyloid cardiomyopathy
Online Access:https://doi.org/10.1002/ehf2.14262

Internet

https://doi.org/10.1002/ehf2.14262

Similar Items